查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855714

按瓣膜类型、手术方式、应用领域和最终用户分類的人工心臟瓣膜市场－2025-2032年全球预测

Prosthetic Heart Valves Market by Valve Type, Procedure, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，人工心臟瓣膜市场规模将达到 277.6 亿美元，复合年增长率为 11.93%。

关键市场统计数据
基准年 2024 112.6亿美元
预计年份：2025年 126.2亿美元
预测年份 2032 277.6亿美元
复合年增长率 (%) 11.93%

本书全面介绍了影响人工心臟瓣膜生态系统的临床驱动因素、技术进步和相关人员动态。

人工心臟瓣膜领域融合了外科手术传统和微创创新，并受到临床需求、人口结构变化和器械技术进步的影响。瓣膜工程和输送系统的进步拓宽了患者在整个生命週期中的治疗选择，并促使临床医生、医院管理者和支付方之间展开更深入的讨论。随着治疗方法的不断发展，製造商和医疗保健系统面临的营运和监管要求也随之改变，促使人们重新评估证据产生、供应链韧性和上市后监测策略。

对外科创新、导管扩张术、材料科学和基于价值的医疗需求所带来的变革性转变进行详细分析

在手术技术创新、材料科学突破以及对以患者为中心的治疗效果日益重视的推动下，人工心臟瓣膜领域正经历着变革性的转变。经导管瓣膜置换术（TVR）技术正迅速成熟，不断拓展适应症，提升围手术期安全性；同时，瓣膜框架几何形状和瓣叶材料的不断改进，也提高了瓣膜的耐久性和血流动力学性能。这些技术进步，加上影像、导航和输送导管的创新，正在降低手术操作的差异性，并拓展复杂解剖结构的手术应用范围。

分析不断变化的美国关税政策和贸易结构调整将如何重塑阀门相关人员的采购、定价和供应链策略。

预期中的关税调整和贸易政策重组将为人工心臟瓣膜领域的相关人员带来新的复杂性，影响其采购、定价和全球供应链策略。关税制度的变化可能会改变进口零件、成品和辅助耗材的成本结构，迫使製造商重新评估采购和生产分配。积极的策略性因应措施包括重新检视供应商合约、探索近岸外包方案以及垂直整合机会，以在维持关键投入品供应的同时，缓解利润率下降的局面。

深入的細項分析揭示了瓣膜类型、手术途径、临床应用和终端用户动态如何决定专门的商业和临床策略。

基于细分市场的洞察揭示了不同瓣膜类型、手术路径、临床应用和终端用户环境下的差异化商业机会和策略重点。在评估瓣膜类型时，机械瓣膜（例如，双隔膜瓣、笼式球瓣和倾斜盘瓣）具有不同的临床特征，会影响后续护理和抗凝血管理；而组织瓣膜（例如，牛、同种异体瓣和猪瓣）则提供了优先考虑生物相容性和减少长期抗凝血需求的方案。这些器械层面的固有差异需要针对性地产生证据并进行临床医生培训，以支持合适的患者选择和长期管理路径。

全面深入的区域洞察，比较美洲、中东和非洲以及亚太地区的监管复杂性、应用驱动因素和商业性路径。

区域动态是监管时间表、产品采纳率和商业模式的关键决定因素，导緻美洲、欧洲、中东和非洲以及亚太地区市场进入路径各不相同。在美洲，成熟的临床生态系统和完善的医保报销体系促进了创新瓣膜技术的快速普及，同时医疗系统也日益关注疗效和成本效益，以此指南采购。相较之下，欧洲、中东和非洲的市场监管和支付方环境各不相同，需要製定细緻的打入市场策略，并利用本地临床证据来支持各地区的市场推广。

了解领先製造商如何透过创新、伙伴关係、证据累积和卓越的供应链管理脱颖而出。

医疗设备製造商之间的竞争力日益取决于临床证据的整合、供应链的韧性以及差异化技术平台。领先企业正投资研发新一代说明书材料、增强耐久性测试以及专有给药系统，以满足尚未满足的临床需求并拓展适应症。与影像和导航公司建立策略联盟以及与学术中心合作，正在加速器械的迭代改进，并透过培训和指导计画鼓励临床医生儘早采用新产品。

为医疗器材开发商和医疗系统领导者提供切实可行的建议，以协调创新、供应链韧性、证据产生和商业性敏捷性

产业领导者应采取一系列切实可行的策略，使研发投资与临床优先事项、营运韧性和商业性灵活性保持一致。首先，应优先开发模组化瓣膜和输送平台，以便进行渐进式升级而无需完全重新手术，从而加快临床医生接受新产品并降低生命週期成本。同时，应投资持久的临床前研究和真实世界证据项目，以衡量以患者为中心的疗效和长期性能，并支持医保报销和适应症扩展。

我们采用透明的调查方法，包括临床医生参与、监管分析和证据三角验证，以深入了解人工瓣膜。

该研究结合了临床医生访谈、采购相关人员和器械开发商简报的第一手资料，并严格审查了同行评审的临床文献、监管申报文件和手术最佳实践指南。主要定性研究邀请了介入性心臟病专家、心臟外科医生、医院采购负责人和临床试验负责人参与，以了解当地对实施障碍、培训需求和手术结果的观点。除了这些直接回馈外，研究还评估了监管文件和已发布的上市后监测数据，以检验不同瓣膜类型和手术方法的性能描述和安全性概况。

总结全文，重点阐述将技术前景转化为持续的临床应用和营运韧性所需的策略要务。

器械创新、手术流程拓展和供应链复杂性的整合，为人工心臟瓣膜领域的企业带来了巨大的机会和新的风险。持久的技术进步和适应症的扩大有望改善患者预后并扩大治疗覆盖范围，但要实现这些益处，需要严谨的循证策略、适应性强的生产方式以及以临床医生为中心的推广模式。随着贸易政策和报销框架的不断演变，采取积极主动、优先考虑韧性和明确价值的策略，对于保持竞争力至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 经导管主动脉瓣置换术在高手术风险老年患者的应用日益增多
  • 开发新型聚合物心臟瓣膜材料，以降低血栓形成倾向并改善动态性能
  • 个人化3D列印技术在设计与安装患者专用人工心臟瓣膜的应用
  • 扩大微创瓣膜置换术在八旬老人的应用，用于治疗生物瓣膜功能衰竭
  • 监管部门的核准加速了新一代球囊扩张型和自扩张式瓣膜的市场准入
  • 加大对经导管二尖瓣和三尖瓣置换疗法适应症扩展试验的投资

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按瓣膜类型分類的人工心臟瓣膜市场

  • 机械的
    • 巴利·阿弗雷特
    • 笼球
    • 倾斜盘
  • 组织
    • 牛
    • 同种异体移植
    • 猪

第九章 依手术方式分類的人工心臟瓣膜市场

  • 手术置换术
    • 微创
    • 传统开放性手术
  • 经导管瓣膜置换术
    • 经尖端
    • 经股骨

第十章 按应用分類的人工心臟瓣膜市场

  • 主动脉
  • 二尖瓣
  • 三尖瓣

第十一章 依最终用户分類的人工心臟瓣膜市场

  • 门诊手术中心
  • 医院

第十二章：按地区分類的人工心臟瓣膜市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 按组别分類的人工心臟瓣膜市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国人工心臟瓣膜市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • CryoLife, Inc.
    • MicroPort Scientific Corporation
    • Braile Biomedica SA
    • JenaValve Technology, Inc.
    • Venus MedTech（Hangzhou）Inc.
Product Code: MRR-62667ADFA787

The Prosthetic Heart Valves Market is projected to grow by USD 27.76 billion at a CAGR of 11.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 11.26 billion
Estimated Year [2025] USD 12.62 billion
Forecast Year [2032] USD 27.76 billion
CAGR (%) 11.93%

Comprehensive introduction framing clinical drivers, technological advances, and stakeholder dynamics reshaping the prosthetic heart valve ecosystem

The prosthetic heart valve sector stands at the intersection of surgical tradition and minimally invasive innovation, shaped by clinical need, demographic shifts, and device technology progress. Advances in valve engineering and delivery systems have expanded therapeutic options for patients across the lifespan, driving more nuanced conversations among clinicians, hospital administrators, and payers. As therapies evolve, so too do the operational and regulatory demands on manufacturers and health systems, prompting a re-evaluation of evidence generation, supply chain resilience, and post-market surveillance strategies.

Transitioning from historical open-heart procedures toward catheter-based interventions has redefined procedural pathways and patient eligibility. Concurrently, the competing design philosophies of mechanical and tissue valves require distinct clinical and commercial approaches, influencing long-term management, follow-up requirements, and prosthesis selection criteria. These dynamics underscore the importance of an integrated perspective that links clinical outcomes, health economics, and real-world adoption patterns to inform strategic decisions across R&D, regulatory affairs, and commercial teams.

Detailed analysis of the transformative shifts driven by surgical innovation, catheter-based expansion, material science, and value-based care imperatives

The prosthetic heart valve landscape is undergoing transformative shifts driven by procedural innovation, material science breakthroughs, and an intensified focus on patient-centred outcomes. Transcatheter valve replacement technologies have matured rapidly, broadening indications and improving peri-procedural safety, while iterative refinements in valve frame geometry and leaflet materials are improving durability and haemodynamic performance. These technical improvements are accompanied by innovations in imaging, navigation, and delivery catheters, which collectively reduce procedural variability and expand access to complex anatomies.

Beyond devices, care delivery models are shifting as multidisciplinary heart teams adopt streamlined pathways that prioritise shorter hospital stays and faster functional recovery. Minimally invasive surgical approaches persist alongside catheter-based treatments, creating a dual-track paradigm where device makers must balance investments across both surgical and transcatheter portfolios. In parallel, reimbursement frameworks and value-based purchasing initiatives are placing greater emphasis on long-term outcomes, quality-of-life metrics, and total cost of care, incentivising manufacturers to demonstrate durable clinical benefit and post-market performance. Taken together, these transformative forces are reshaping competitive positioning, regulatory strategies, and clinical adoption trajectories in a market defined by rapid technological evolution and heightened expectations from clinicians and payers.

Examination of how evolving United States tariff policies and trade realignments could reshape procurement, pricing, and supply chain strategies for valve stakeholders

Anticipated tariff adjustments and trade policy realignments will introduce new layers of complexity into procurement, pricing, and global supply chain strategies for stakeholders in the prosthetic heart valve space. Changes in tariff regimes have the potential to alter cost structures for imported components, finished devices, and ancillary disposables, prompting manufacturers to reassess sourcing footprints and manufacturing allocation. A strategic and proactive response involves re-examining supplier contracts, nearshoring options, and vertical integration opportunities to mitigate margin compression while preserving access to critical inputs.

In addition to direct cost impacts, tariff-related shifts may induce changes in competitive dynamics across regional markets. Manufacturers with existing local manufacturing capabilities or favourable trade agreements will experience relative advantage in procurement discussions, whereas those reliant on cross-border supply chains may face pressure on pricing and lead times. Health systems and ambulatory surgical centres may respond by prioritising value and supply resilience in purchasing decisions, thereby elevating the importance of demonstrable total-cost-of-care benefits and reliable inventory management. Consequently, industry participants should develop flexible pricing architectures and scenario-based supply chain plans that account for tariff volatility and evolving trade policies.

Insightful segmentation analysis revealing how valve type, procedural pathway, clinical application, and end-user dynamics dictate specialised commercial and clinical strategies

Segmentation-driven insights reveal differentiated opportunities and strategic priorities across valve types, procedural channels, clinical applications, and end-user settings. When evaluating valve type, mechanical prostheses-comprising bileaflet, caged ball, and tilting disc designs-present distinct clinical profiles that influence follow-up care and anticoagulation management, while tissue valves-spanning bovine, homograft, and porcine options-offer alternatives prioritising biocompatibility and reduced long-term anticoagulation requirements. These intrinsic device-level differences necessitate tailored evidence generation and clinician education to support appropriate patient selection and long-term management pathways.

Procedure segmentation further nuances go-to-market strategies as surgical replacement pathways, including minimally invasive and traditional sternotomy approaches, coexist with transcatheter valve replacement options executed via transapical and transfemoral access. Manufacturers must therefore calibrate their clinical trials, training programs, and delivery system designs to address access-specific technical constraints and operator preferences. Application-based perspectives focused on aortic, mitral, and tricuspid valve interventions require device optimisation for anatomical variability, durability demands, and imaging compatibility. Finally, end-user segmentation between ambulatory surgical centers and hospitals influences purchasing timelines, capital equipment considerations, and procedural throughput expectations, shaping sales cycles and service model requirements. Integrating these segmentation lenses enables more precise product positioning, evidence strategies, and commercial resource allocation.

Comprehensive regional insights that contrast regulatory complexity, adoption drivers, and commercial pathways across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics are a primary determinant of regulatory timelines, adoption rates, and commercial models, creating diverse pathways to market across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, mature clinical ecosystems and established reimbursement infrastructures facilitate rapid uptake of innovative valve technologies, while health systems increasingly emphasise outcomes and cost-effectiveness to guide procurement. Conversely, markets within Europe, Middle East & Africa feature heterogeneous regulatory environments and varied payer landscapes, requiring nuanced market entry strategies and locally generated clinical evidence to support adoption across sub-regions.

The Asia-Pacific region presents a dual opportunity set, characterised by large patient populations and rapidly expanding procedural capacity, alongside regulatory modernisation and growing investments in domestic manufacturing. Manufacturers aiming to scale in Asia-Pacific must develop culturally attuned clinician engagement programs, flexible pricing models, and supply chain solutions that address regional logistics. Across all regions, strategic alliances with clinical leaders, investments in local data generation, and adaptive commercial models will be critical to navigating differing regulatory expectations, reimbursement policies, and hospital procurement practices. A regionalised approach that balances global standards with local execution is therefore essential for sustainable growth.

In-depth view of how leading manufacturers are differentiating through innovation, partnerships, evidence generation, and supply chain excellence

Competitive dynamics among device manufacturers are increasingly defined by the integration of clinical evidence, supply chain resilience, and differentiated technology platforms. Leading firms are investing in next-generation leaflet materials, enhanced durability testing, and purpose-built delivery systems to address unmet clinical needs and expand indication sets. Strategic partnerships with imaging and navigation companies, as well as collaborations with academic centres, are accelerating iterative device improvements and facilitating earlier clinician adoption through training and proctoring programs.

Beyond product innovation, successful companies demonstrate robust post-market surveillance and patient follow-up frameworks that reinforce clinician confidence and support reimbursement dialogues. Operational excellence in manufacturing and quality assurance, combined with flexible commercial models-including capital-light service offerings and outcomes-based contracting pilots-further differentiates market leaders. As procurement teams increasingly prioritise total cost of care and long-term outcomes, companies that can align clinical evidence with economic arguments and reliable supply will secure stronger positioning in competitive tenders and hospital formularies.

Actionable recommendations for device developers and health system leaders to align innovation, supply resilience, evidence generation, and commercial agility

Industry leaders should pursue a set of actionable strategies that align R&D investment with clinical priorities, operational resilience, and commercial agility. First, prioritise modular valve and delivery platform development that allows incremental upgrades without requiring full procedural retraining, thereby accelerating clinician adoption and reducing lifecycle costs. Concurrently, invest in durable preclinical and real-world evidence programmes that measure patient-centric outcomes and long-term performance to support reimbursement and expanded indications.

Second, develop flexible manufacturing and sourcing strategies to mitigate trade policy and tariff risk, including assessing nearshoring and multi-sourcing options for critical components. Strengthen post-market surveillance and registries to provide transparent safety and performance data that drive payer and clinician confidence. Third, tailor commercial approaches to distinct end-user needs by offering training bundles and service models adapted to the workflows of ambulatory surgical centres and hospitals. Finally, cultivate strategic partnerships with imaging, navigation, and digital health companies to enhance procedural precision and enable integrated care pathways. By executing these priorities, organisations can enhance resilience, accelerate adoption, and demonstrate clear value to clinicians, patients, and payers.

Transparent research methodology describing clinician engagements, regulatory analysis, and evidence triangulation used to derive prosthetic valve insights

This research synthesises primary insights from clinician interviews, procurement stakeholder consultations, and device developer briefings, combined with a rigorous review of peer-reviewed clinical literature, regulatory filings, and procedural best-practice guidelines. Primary qualitative engagements targeted interventional cardiologists, cardiac surgeons, hospital procurement leaders, and clinical trialists to capture frontline perspectives on adoption barriers, training needs, and procedural outcomes. These direct inputs were complemented by an assessment of regulatory documents and published post-market surveillance data to validate performance narratives and safety profiles across valve types and procedural approaches.

Analytical methods included thematic coding of qualitative interviews, cross-validation of device performance claims against regulatory summaries, and scenario analysis to explore supply chain and tariff sensitivities. Wherever possible, evidence triangulation was used to reconcile clinician-reported experiences with registry publications and regulatory decisions. The methodology emphasises transparency in data sources and incorporates stakeholder validation to ensure that conclusions reflect real-world operational and clinical realities rather than solely promotional narratives.

Conclusive synthesis emphasising the strategic imperatives needed to translate technological promise into sustained clinical adoption and operational resilience

The convergence of device innovation, procedural expansion, and supply chain complexity is creating both significant opportunities and novel risks for organisations operating in the prosthetic heart valve domain. Durable technological improvements and expanding indications have the potential to improve patient outcomes and broaden therapy access, but realising those benefits requires disciplined evidence strategies, adaptive manufacturing, and clinician-focused deployment models. As trade policies and reimbursement frameworks evolve, a proactive posture that prioritises resilience and clear value articulation will be essential to maintain competitive positioning.

Looking ahead, stakeholders that integrate rigorous clinical evidence, flexible commercial models, and robust supply chain planning will be better positioned to capitalise on clinical advances while mitigating policy and market volatility. Cross-functional collaboration across clinical, regulatory, and commercial teams will be critical to translating innovation into sustained adoption and improved patient care. Ultimately, success will be defined by the ability to align technological promise with practical implementation strategies that deliver measurable benefits to patients and health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of transcatheter aortic valve implantation in high surgical risk and elderly patients
  • 5.2. Development of novel polymeric heart valve materials to reduce thrombogenicity and enhance hemodynamic performance
  • 5.3. Emergence of personalized 3D printing techniques for patient-specific prosthetic heart valve design and fit
  • 5.4. Expansion of minimally invasive valve-in-valve implantation procedures for failed bioprosthetic valves in octogenarians
  • 5.5. Regulatory approvals accelerating market entry of next-generation balloon expandable and self expanding valves
  • 5.6. Growing investment in extended indication trials for transcatheter mitral and tricuspid valve replacement therapies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Prosthetic Heart Valves Market, by Valve Type

  • 8.1. Mechanical
    • 8.1.1. Bileaflet
    • 8.1.2. Caged Ball
    • 8.1.3. Tilting Disc
  • 8.2. Tissue
    • 8.2.1. Bovine
    • 8.2.2. Homograft
    • 8.2.3. Porcine

9. Prosthetic Heart Valves Market, by Procedure

  • 9.1. Surgical Replacement
    • 9.1.1. Minimally Invasive
    • 9.1.2. Traditional Sternotomy
  • 9.2. Transcatheter Valve Replacement
    • 9.2.1. Transapical
    • 9.2.2. Transfemoral

10. Prosthetic Heart Valves Market, by Application

  • 10.1. Aortic
  • 10.2. Mitral
  • 10.3. Tricuspid

11. Prosthetic Heart Valves Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Prosthetic Heart Valves Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Prosthetic Heart Valves Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Prosthetic Heart Valves Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Edwards Lifesciences Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Abbott Laboratories
    • 15.3.4. Boston Scientific Corporation
    • 15.3.5. LivaNova PLC
    • 15.3.6. CryoLife, Inc.
    • 15.3.7. MicroPort Scientific Corporation
    • 15.3.8. Braile Biomedica S.A.
    • 15.3.9. JenaValve Technology, Inc.
    • 15.3.10. Venus MedTech (Hangzhou) Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. PROSTHETIC HEART VALVES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. PROSTHETIC HEART VALVES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PROSTHETIC HEART VALVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY CAGED BALL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY BOVINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PORCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRADITIONAL STERNOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSAPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSFEMORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AORTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MITRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
  • TABLE 306. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
  • TABLE 307. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 308. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 309. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 310. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 311. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 312. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 313. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 314. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 315. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION PROSTHET